7Treatment of relevant services

7 Treatment of relevant services

For subsection 3C(1) of the Act, a relevant service, provided in accordance with this instrument and as a clinically relevant service, is to be treated, for the relevant provisions, as if: (a) it were both a professional service and a medical service; and (b) there were an item in the pathology services table that is related to the service.

Schedule 1—Relevant services

<table cellspacing="0" cellpadding="0" style="width:438.65pt; border-collapse:collapse"><thead><tr><td colspan="3" style="width:427.95pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Group P9— Simple Basic Pathology Tests</span></p></td></tr><tr><td style="width:58.95pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Column 1</span></p><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Item</span></p></td><td style="width:283.4pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #ffffff; border-bottom:1.5pt solid #000000; padding-right:4.97pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Column 2</span></p><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Description</span></p></td><td style="width:64.2pt; border-top:1.5pt solid #000000; border-left:0.75pt solid #ffffff; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:4.97pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Column 3</span></p><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Fee ($)</span></p></td></tr></thead><tbody><tr style="height:41.4pt"><td style="width:58.95pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; line-height:normal; font-size:10pt"><span>73839</span></p></td><td style="width:283.4pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #ffffff; border-bottom:0.75pt solid #000000; padding-right:4.97pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; line-height:normal; font-size:10pt"><span>Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk - not more than once in a 12 month period</span></p></td><td style="width:64.2pt; border-top:1.5pt solid #000000; border-left:0.75pt solid #ffffff; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:4.97pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>16.80</span></p></td></tr><tr style="height:41.8pt"><td style="width:58.95pt; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; line-height:normal; font-size:10pt"><span>73840</span></p></td><td style="width:283.4pt; border-top:0.75pt solid #000000; border-right:0.75pt solid #ffffff; border-bottom:0.75pt solid #000000; padding-right:4.97pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; line-height:normal; font-size:10pt"><span>Quantitation of glycosylated haemoglobin performed in the management of established diabetes – each test to a maximum of 4 tests in a 12 month period</span></p></td><td style="width:64.2pt; border-top:0.75pt solid #000000; border-left:0.75pt solid #ffffff; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:4.97pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>17.00</span></p></td></tr><tr style="height:42.4pt"><td style="width:58.95pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; line-height:normal; font-size:10pt"><span>73844</span></p></td><td style="width:283.4pt; border-top:0.75pt solid #000000; border-right:0.75pt solid #ffffff; border-bottom:1.5pt solid #000000; padding-right:4.97pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; line-height:normal; font-size:10pt"><span>Quantitation of urinary albumin/creatine ratio in urine on a random spot collection in the management of patients with established diabetes or patients at risk of microalbuminuria</span></p></td><td style="width:64.2pt; border-top:0.75pt solid #000000; border-left:0.75pt solid #ffffff; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:4.97pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>20.35</span></p></td></tr></tbody></table>